13D/13G Filings - PLATINUM ASSET MANAGEMENT LTD

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-11-06
7:56 pm
Sale
2024-09-30 13G NanoString Technologies, Inc.
NSTGQ
PLATINUM ASSET MANAGEMENT LTD 0
0.000%
-2,775,853decrease
(Position Closed)
Filing
History
2024-11-06
7:53 pm
Sale
2024-09-30 13G Kazia Therapeutics Limited
KZIA
PLATINUM ASSET MANAGEMENT LTD 0
0.000%
-36,438decrease
(Position Closed)
Filing
History
2024-11-06
7:47 pm
Sale
2024-03-31 13G CENTOGENE N V COM SHS USD
CNTGF
PLATINUM ASSET MANAGEMENT LTD 1,186,102
4.260%
-1,073,761decrease
(-47.51%)
Filing
History
2024-02-13
10:37 am
Sale
2023-12-31 13G Icosavax, Inc.
ICVX
PLATINUM ASSET MANAGEMENT LTD 1,380,618
2.440%
-869,093decrease
(-38.63%)
Filing
History
2024-02-12
6:35 pm
Purchase
2023-12-31 13G Kazia Therapeutics Limited
KZIA
PLATINUM ASSET MANAGEMENT LTD 36,438
6.910%
36,438increase
(New Position)
Filing
History
2024-02-12
6:13 pm
Purchase
2023-12-31 13G NanoString Technologies, Inc.
NSTGQ
PLATINUM ASSET MANAGEMENT LTD 2,775,853
5.700%
2,775,853increase
(New Position)
Filing
History
2023-02-09
10:31 am
Purchase
2022-12-31 13G Icosavax, Inc.
ICVX
PLATINUM ASSET MANAGEMENT LTD 2,249,711
5.250%
2,249,711increase
(New Position)
Filing
History
2022-02-10
5:25 pm
Purchase
2021-12-31 13G Esperion Therapeutics, Inc.
ESPR
PLATINUM ASSET MANAGEMENT LTD 2,713,176
3.940%
2,713,176increase
(New Position)
Filing
History
2021-12-08
8:52 pm
Purchase
2021-11-30 13G CENTOGENE N V COM SHS USD
CNTGF
PLATINUM ASSET MANAGEMENT LTD 2,259,863
10.220%
2,259,863increase
(New Position)
Filing
History
2021-02-11
7:45 pm
Unchanged
2021-02-11 13G Esperion Therapeutics, Inc.
ESPR
PLATINUM ASSET MANAGEMENT LTD 0
0.000%
0
(Unchanged)
Filing